Clotrimazole Solution

Manufacturer
Marlex Pharmaceuticals Inc
Effective date
2025-10-08
Label type
HUMAN OTC DRUG LABEL
Version
8
Source
full-release
Hydrated at
2026-06-01 01:38:24

Label at a glance#

ProductClotrimazole
Active ingredientCLOTRIMAZOLE
Label structure11 sections

Indications and uses

Cures most Athlete's foot (tinea pedis) Jock Itch (tinea cruris) Ringworm (tinea corporis) Effectively relieves Itching Cracking Burning Discomfort which can accompany these conditions

Dosage and administration

This product is not effective on the scalp or nails For best results, follow directions and continue treatment for length of time indicated. For athlete's foot and ringworm: use daily for 4 weeks. For jock itch: use daily for 2 weeks. clean the affected area and dry thoroughly apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor supervise children in the u...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

CLOTRIMAZOLE -clotrimazolesolutionMarlexPharmaceuticals, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

ClotrimazoleTopical Solution USP,1%

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Clotrimazole USP, 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

Cures most

  • Athlete's foot (tinea pedis)
  • Jock Itch (tinea cruris)
  • Ringworm (tinea corporis)

Effectively relieves

  • Itching
  • Cracking
  • Burning

Discomfort which can accompany these conditions

Warnings

WARNINGS SECTION

For external use only

Ask a doctor before use

OTC - ASK DOCTOR SECTION

on children under 2 years of age

When using this product

OTC - WHEN USING SECTION

avoid contact with eyes

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • irritation occurs
  • there is no improvement within 4 weeks (for athlete's foot and ringworm) or 2 weeks (for jock itch)

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • This product is not effective on the scalp or nails For best results, follow directions and continue treatment for length of time indicated. For athlete's foot and ringworm: use daily for 4 weeks. For jock itch: use daily for 2 weeks.
  • clean the affected area and dry thoroughly
  • apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor
  • supervise children in the use of this product

For athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes; change shoes and socks at least once daily

Other information

SAFE HANDLING WARNING SECTION

  • Store at 15° to 30°C (59° to 86°F)

Inactive ingredient

INACTIVE INGREDIENT SECTION

polyethylene glycol

INFORMATION FOR OWNERS/CAREGIVERS SECTION

keep this carton for important information.

Manufactured for and Distributed by:

Marlex Pharmaceuticals, Inc.

New Castle, DE 19720

ϯ All trademarks are property of their respective owners. This product is not affiliated with the makers/owners of Lotrimin®AF.

Rev. 11/18 IT

PRINCIPAL DISPLAY PANEL - 10 mL Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Rev. 11/18 IT

NDC 10135-0671-81
Clotrimazole
Topical Solution
USP, 1 %
10 mL

671-81671-81

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Rev. 01/20 IT

NDC 10135-0671-91
Clotrimazole
Topical Solution
USP, 1 %
30 mL

PRINCIPAL DISPLAY PANEL NDC 10135-0671-91 Clotrimazole Topical Solution USP, 1 % 30 mL Rx OnlyPRINCIPAL DISPLAY PANEL NDC 10135-0671-91 Clotrimazole Topical Solution USP, 1 % 30 mL Rx Only

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CLOTRIMAZOLE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b64d2752-34ef-378a-1f4f-8bff32b0d1aeProduct name420250626
cb7783e0-feaa-7e56-fb3b-d43b6efa77c9Product name220250121
f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6Product name220151106
f5395dd2-4395-d8c6-3477-8c2d4a2f951cProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10135-671-81Clotrimazole10 mL in 1 BOTTLESOLUTION108
10135-671-81Clotrimazole1 in 1 CARTONSOLUTION18
10135-671-91Clotrimazole1 in 1 CARTONSOLUTION18
10135-671-91Clotrimazole30 mL in 1 BOTTLESOLUTION308

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
10135-671-81ML - Milliliter10135-67120b9cd43-b3b8-45ab-b185-aa435e24717a12019-01-24
10135-671-91ML - Milliliter10135-671c004140e-3550-406d-8686-1fc7bb50526d12020-04-20

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10135-67110135-671-81, 10135-671-91

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
POLYETHYLENE GLYCOL 400B697894SGQIACT
CLOTRIMAZOLEG07GZ97H65ACTIB

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
72024-07-18full-release2026-06-01 00:15:36

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ClotrimazoleCLOTRIMAZOLEMarlex Pharmaceuticals Incd6e95c99-e055-436a-8ee6-40d6e199eaca2025-10-08WarningsExact identifier
ndc (package): 10135-671-81
ndc (package): 10135-671-91
ndc (product): 10135-671
ndc11 (package): 10135067181
ndc11 (package): 10135067191
spl id: 40a87948-bcf6-0552-e063-6394a90a2d0d
spl set id: d6e95c99-e055-436a-8ee6-40d6e199eaca

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.